RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
Active, not recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1989-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining radiation therapy with combination chemotherapy may kill
more tumor cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with no
radiation therapy following chemotherapy in treating patients with stage III or stage IV
Hodgkin's disease.
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Completed
National Cancer Institute (NCI)
Phase 2
1989-02-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine,
vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive
neuroectodermal tumors.
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
Completed
M.D. Anderson Cancer Center
Phase 2
1989-02-01
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine,
vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive
neuroectodermal tumors.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
